FDA releases guidance on using EHRs in clinical trials

A draft guidance from the U.S. Food and Drug Administration seeks to assist parties that use EHRs in FDA-regulated clinical investigations.

The guidance recommendations cover four main areas: Whether and how to use EHRs as a source of data, using EHRs that are interoperable with electronic systems supporting clinical investigations, ensuring the quality and integrity of EHR data used, and ensuring the EHR data collected and used meets FDA requirements.

Using EHRs in clinical trials can help modernize and streamline such investigations, according to the guidance.

The guidance is still in draft form, and the FDA seeks comments and suggestions on the document. To read the guidance, click here.

More articles on EHRs:

38% of execs want telemedicine programs built onto their EHRs & 6 other survey takeaways 
Can EHRs predict flu outbreaks? 
Just 2 in 10 consumers use EHR data to make medical decisions 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars

>